Oncodesign Precision Medicine (OPM)

Last updated September 27, 2026

Organization details

Legal name
Oncodesign Precision Medicine (OPM)
Also known as (brands, DBAs, abbreviations)
Oncodesign PM
Ownership
Public
Status
Active
Headquarters city
Dijon
Headquarters country
France
Ticker symbol
ALOPM
Primary stock exchange
Euronext

Identifiers

LEI
969500ZDX1IY47LDL876
ISIN
FR001400CM63

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.